RxDoctor Payments Data

Karen Fischer

Adult Health · St Joseph, MONPI 1295047504

Payments from drug & device makers

$3,904in general payments, 2019–2025

Across 242 payments — averaging $16.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$440
  • E.r. Squibb & Sons, L.L.C.$375
  • Johnson & Johnson$308
  • Boehringer Ingelheim$283
  • AstraZeneca$274
  • Pfizer$219
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$3,904100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,904 in reported general payments places this provider in the 85th percentile of 555 adult health providers in Missouri.

See all adult health providers in Missouri

Medicare billing

Part B allowed, 2024
$96,891
Medicare patients
1,079
Services billed
2,100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan234$222,808
EliquisApixaban150$149,342
XareltoRivaroxaban119$114,270
JardianceEmpagliflozin96$109,451
Repatha SureclickEvolocumab46$56,053
Praluent PenAlirocumab18$13,529
Ranolazine ErRanolazine161$12,672
FarxigaDapagliflozin Propanediol11$10,472
VascepaIcosapent Ethyl12$9,875
Rosuvastatin Calcium720$9,108
Metoprolol Succinate514$8,620
Valsartan165$5,173
Carvedilol545$4,501
Torsemide431$4,454
Atorvastatin Calcium512$4,411

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$192$222,808234 claims
PfizerEliquis$219$149,342150 claims
Johnson & JohnsonXarelto$308$114,270119 claims
Boehringer IngelheimJardiance$283$109,45196 claims
AstraZenecaFarxiga$274$10,47211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 555 adult health providers in Missouri.

Other adult health in St Joseph

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →